$45.58
-1.93 (-4.06%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+13.6% upside
Low Target
$39.42
Average Target
$51.79
High Target
$66.87
Current Price
$45.58
Current
$45.58
$45.58
Target
$51.79
$51.79
$39.42
$51.79 avg
$66.87
Scenario Analysis
Bear Case
$39.42
-13.5%
Low target
Base Case
$51.79
+13.6%
Avg target
Bull Case
$66.87
+46.7%
High target
Risk/Reward
3.5x
Highly favorable
Price in Context
52-Week High
$72.36
-37.0% from high
52-Week Low
$20.18
+125.9% from low
Target vs 52W High
$51.79
-28.4% vs high
Next Earnings Report
Nov 10, 2026 · After Market Close
2d
until earnings
EPS Est: $0.61
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |